396 A Phase I, Dose-finding Study of BI 853520, a Potent and Selective Inhibitor of Protein Tyrosine Kinase 2 in Patients with Advanced or Metastatic Solid Tumors
de Jonge, M., Sahebjam, S., Mathijssen, R.H., Razak, A., van der Biessen, D., Pronk, L.C., Schnell, D., Siu, L.L.Volume:
48
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(12)72194-9
Date:
November, 2012
File:
PDF, 79 KB
english, 2012